Indaba Capital Management, L.P. 13D and 13G filings for Standard BioTools Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 3:32 pm Sale |
2024-09-30 | 13G | Standard BioTools Inc. LAB |
Indaba Capital Management, L.P. | 2,641,379 0.700% |
-5,333,995 (-66.88%) |
Filing |
| 2024-02-14 3:32 pm Purchase |
2023-12-31 | 13G | Standard BioTools Inc. LAB |
Indaba Capital Management, L.P. | 7,975,374 9.900% |
80,623 (+1.02%) |
Filing |
| 2023-02-14 10:26 am Purchase |
2022-12-31 | 13G | Standard BioTools Inc. LAB |
Indaba Capital Management, L.P. | 7,894,751 9.900% |
308,846 (+4.07%) |
Filing |
| 2022-02-14 3:46 pm Purchase |
2021-12-31 | 13G | Standard BioTools Inc. LAB |
Indaba Capital Management, L.P. | 7,585,905 9.900% |
49,555 (+0.66%) |
Filing |
| 2021-02-16 3:33 pm Purchase |
2020-12-31 | 13G | Standard BioTools Inc. LAB |
Indaba Capital Management, L.P. | 7,536,350 9.900% |
257,826 (+3.54%) |
Filing |